Bayer sold its animal health division to Elanco Animal Health Incorporated for $5.17 billion. Bayer also acquired 72.9 million shares in Elanco, equivalent to 15.5% of the company. After the ban on the sale expired in mid-2021, Bayer plans to withdraw from Elanco.